Mann Foundation for Biomedical Engineering

The Alfred Mann Foundation for Biomedical Engineering (AMF) is a non-profit medical research organization dedicated to developing innovative medical technologies for patients with debilitating diseases. Founded in 1985 by entrepreneur Alfred E. Mann, the foundation focuses on bridging the gap between basic research and commercial availability by incubating sophisticated medical devices through clinical trials. AMF has been instrumental in the development of groundbreaking technologies such as the modern cochlear implant, the rechargeable pacemaker, and the insulin pump. The foundation typically spins off its successful technologies into independent commercial entities or licenses them to major industry leaders like Medtronic and Boston Scientific. Currently, AMF continues to advance its proprietary Implantable Myoelectric Sensor (IMES) and Bionic Neuron (BION) platforms to improve the lives of individuals with limb loss and paralysis.